Document is current
Any future updates will be listed below
-
Authors
Erkes, Annett
Grove, René P.
Žarković, Milena
Krautwurst, Sebastian
Koebnik, Ralf
Morgan, Richard D.
Wilson, Geoffrey G.
Hölzer, Martin
Marz, Manja
Boch, Jens
Grau, Jan
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FZT 118/2, FZT 118/2, BO 1496/8-2, GR 4587/1-2)
Thüringer Ministerium für Wirtschaft, Wissenschaft und Digitale Gesellschaft (DigLeben-5575/10-9, DigLeben-5575/10-9)
Agence Nationale de la Recherche (ANR-2010-BLAN-1723)
Martin-Luther-Universität Halle-Wittenberg
- License Information
-
More Information
Article History
Received: 26 September 2022
Accepted: 6 March 2023
First Online: 27 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: GGW and RDM are employees of New England Biolabs Inc., Ipswich, USA. JB is a part owner of patents governing the use of transcription activator-like effectors (TALEs). AE, RPG, MZ, SK, RK, MH, MM, and JG declare that they have no competing interests.
